Together Pharma Ltd (TLV:TGTR)

Together Pharma Statistics

Total Valuation

Together Pharma has a market cap or net worth of ILS 57.21 million. The enterprise value is 100.31 million.

Market Cap	57.21M
Enterprise Value	100.31M

Important Dates

The next estimated earnings date is Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Together Pharma has 17.35 million shares outstanding. The number of shares has increased by 41.07% in one year.

Current Share Class	17.35M
Shares Outstanding	17.35M
Shares Change (YoY)	+41.07%
Shares Change (QoQ)	+3.44%
Owned by Insiders (%)	75.15%
Owned by Institutions (%)	0.00%
Float	4.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.52
PB Ratio	1.15
P/TBV Ratio	2.74
P/FCF Ratio	6.21
P/OCF Ratio	5.91
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.68, with an EV/FCF ratio of 10.89.

EV / Earnings	-15.29
EV / Sales	0.92
EV / EBITDA	13.68
EV / EBIT	267.49
EV / FCF	10.89

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 1.01.

Current Ratio	1.11
Quick Ratio	0.43
Debt / Equity	1.01
Debt / EBITDA	6.80
Debt / FCF	5.41
Interest Coverage	0.05

Financial Efficiency

Return on equity (ROE) is -14.88% and return on invested capital (ROIC) is 0.23%.

Return on Equity (ROE)	-14.88%
Return on Assets (ROA)	0.15%
Return on Invested Capital (ROIC)	0.23%
Return on Capital Employed (ROCE)	0.52%
Revenue Per Employee	548,834
Profits Per Employee	-32,975
Employee Count	199
Asset Turnover	0.71
Inventory Turnover	1.54

Taxes

Income Tax	-975,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.71% in the last 52 weeks. The beta is 0.23, so Together Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	-40.71%
50-Day Moving Average	362.72
200-Day Moving Average	402.79
Relative Strength Index (RSI)	42.15
Average Volume (20 Days)	7,799

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Together Pharma had revenue of ILS 109.22 million and -6.56 million in losses. Loss per share was -0.51.

Revenue	109.22M
Gross Profit	17.12M
Operating Income	375,000
Pretax Income	-8.20M
Net Income	-6.56M
EBITDA	6.16M
EBIT	375,000
Loss Per Share	-0.51

Balance Sheet

The company has 9.56 million in cash and 49.87 million in debt, giving a net cash position of -40.31 million or -2.32 per share.

Cash & Cash Equivalents	9.56M
Total Debt	49.87M
Net Cash	-40.31M
Net Cash Per Share	-2.32
Equity (Book Value)	49.57M
Book Value Per Share	3.28
Working Capital	8.62M

Cash Flow

In the last 12 months, operating cash flow was 9.69 million and capital expenditures -473,000, giving a free cash flow of 9.21 million.

Operating Cash Flow	9.69M
Capital Expenditures	-473,000
Free Cash Flow	9.21M
FCF Per Share	0.53

Margins

Gross margin is 15.67%, with operating and profit margins of 0.34% and -6.01%.

Gross Margin	15.67%
Operating Margin	0.34%
Pretax Margin	-7.51%
Profit Margin	-6.01%
EBITDA Margin	5.64%
EBIT Margin	0.34%
FCF Margin	8.44%

Dividends & Yields

Together Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.07%
Shareholder Yield	-41.07%
Earnings Yield	-11.47%
FCF Yield	16.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 13, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date	Aug 13, 2023
Split Type	Reverse
Split Ratio	0.1

Scores

Together Pharma has an Altman Z-Score of -0.81 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.81
Piotroski F-Score	6